Table 1.
General information regarding patients undergoing IVF/ICSI treatment.
| Characteristic |
Late stimulation group (n = 116) |
Progesterone group (n = 288) |
P-value |
|---|---|---|---|
| Age (years) | 31.85 (3.08) | 31.85 (3.67) | 0.921 |
| BMI (kg/m2) | 20.69 (1.8) | 20.9 (1.69) | 0.159 |
| Duration of infertility (years) | 3.31 (2.5) | 3.25 (2.28) | 0.855 |
| Type of infertility n (%) | 0.198 | ||
| Primary | 69 (59.5) | 151 (52.43) | |
| Secondary | 47 (40.5) | 137 (47.57) | |
| Antral follicle counts (n) | 10.97 (4.8) | 11.77 (6.53) | 0.977 |
| Indication for IVF/ICSI treatments (n) | 0.574 | ||
| Tubal factor | 75 | 172 | |
| Male factor | 11 | 41 | |
| Unknown factor | 11 | 24 | |
| Combined factors | 19 | 51 | |
| Basal FSH (IU/L) | 5.47 (1.15) | 5.47 (1.25) | 0.979 |
| Basal LH (IU/L) | 3.62 (1.63) | 3.88 (2.26) | 0.686 |
| Basal E2 (pg/mL) | 36.23 (16.95) | 36.03 (18.5) | 0.658 |
| Basal P (ng/mL) | 0.31 (0.12) | 0.3 (0.22) | 0.1 |